Sahil Kirpekar, MD

Sahil Kirpekar, MD is the Chief Business Officer at atai Life Sciences, a company focused on building the life sciences industry of the future.1 He is based in New York and has over 500 connections on LinkedIn.1

Dr. Kirpekar has a strong background in the pharmaceutical and healthcare industries. He received his education from the University of Cambridge, which likely contributes to his expertise in the field.1

In his role at atai Life Sciences, Dr. Kirpekar is involved in various aspects of the company's operations and strategic development. He has been active in industry events, as evidenced by his upcoming speaking engagement at the Abu Dhabi Global Healthcare Week 2024.2

Prior to his current position, Dr. Kirpekar held roles in business development at other pharmaceutical companies. He previously worked as an Associate Director at the MCQuade Center for Strategic Research and Development at Otsuka Pharmaceutical Companies (U.S.).34

Dr. Kirpekar appears to be passionate about innovation in healthcare and pharmaceutical development, often using hashtags like #defylimitation and #roadto2030 in his professional communications.35 This suggests he is focused on pushing boundaries and looking towards future advancements in the life sciences sector.